Skip to main content

Nonprofit · EIN 26-3331487

GLOBAL GENES

Also known as The Project The Project-The Children's Rare Disease Network, The Project-The Children's Rare Disease Network

Tax-exempt · WASHINGTON, DC 20005

Financials

$8.5M$8.6M2023$7.1M$7.4M2024
Revenue Expenses · by fiscal year end
Financials of GLOBAL GENES by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$7,145,531$7,415,893-$270,362$1,538,482$1,351,107$187,375
December 31, 2023990$8,469,402$8,561,859-$92,457$2,099,140$1,641,403$457,737
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$5,686,341
Program service revenue
$1,449,717
Investment income
$9,473
Other revenue
$0

Expenses

Grants and similar amounts paid
$175,264
Compensation of officers, directors and key employees
$711,308
Other salaries and wages
$2,848,775
Salaries, compensation and benefits (total)
$3,960,600
Professional fundraising fees
$0
Legal fees
$7,417
Accounting fees
$61,310
Occupancy
$78,909
Travel
$137,940
Program services (functional)
$5,861,349
Management and general (functional)
$954,354
Fundraising (functional)
$600,190

Balance sheet and other

Total assets, start of year
$2,099,140
Total assets, end of year
$1,538,482
Total liabilities, end of year
$1,351,107
Net assets, end of year
$187,375
Net assets without donor restrictions
-$1,318,314
Net assets with donor restrictions
$1,505,689
Gross receipts
$7,145,531
Employees
38
Volunteers
42
Year formed
2008
State of legal domicile
CA

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
CHARLENE SON RIGBYCEO
Officer
40$319,125$836
NICOLE R BOICEFOUNDER & CHIEF MISSION OFFICER
Trustee or director, Officer
40$254,375$86
KARMEN TRZUPEKSENIOR DIRECTOR, SCIENTIFIC PROGRAMS
Highest-paid employee
40$179,287$6,386
ZOHREH TALEBIZADEHSENIOR DIRECTOR, RARE-X RESEARCH PROGRAM
Highest-paid employee
40$180,000$86
LAUREN ALFORDSENIOR DIRECTOR, MARKETING
Highest-paid employee
40$168,506$86
CHWENWOAN KUANDIRECTOR, PROGRAM OPERATIONS
Highest-paid employee
40$146,285$6,062
TIMOTHY EHRHARDSENIOR DIRECTOR, IT (TERM 12/24)
Highest-paid employee
40$151,746$86
VICTORIA WEISSSENIOR DIRECTOR, FINANCE
Officer
24$136,800$86
WALT KOWTONIUKCHAIR
Trustee or director, Officer
1$0$0
KATHERINE MAYNARDVICE CHAIR
Trustee or director, Officer
1$0$0
SIMON FROSTCFO
Trustee or director, Officer
1$0$0
CHRISTINA HARTMANSECRETARY
Trustee or director, Officer
1$0$0
BETSY BOGARDDIRECTOR
Trustee or director
1$0$0
KHRYSTAL DAVISDIRECTOR
Trustee or director
1$0$0
ILANA FOGELMANDIRECTOR
Trustee or director
1$0$0
11 more people on this return
NameTitleHours / weekCompensation
PETER GOODHANDDIRECTOR
Trustee or director
1$0
HUGH HEMPELDIRECTOR
Trustee or director
1$0
RAM IYERDIRECTOR
Trustee or director
1$0
NEIL KUMARDIRECTOR
Trustee or director
1$0
CAROLINE LOEWYDIRECTOR
Trustee or director
1$0
INDU NAVARDIRECTOR
Trustee or director
1$0
DAVID PEARCEDIRECTOR
Trustee or director
1$0
JOHN REYNDERSDIRECTOR
Trustee or director
1$0
MORRIE RUFFINDIRECTOR
Trustee or director
1$0
ALVIN SHIHDIRECTOR
Trustee or director
1$0
KELLY MCVEARRYDIRECTOR
Trustee or director
1$0
990 for the year ended December 31, 2023: 25 people
NameTitleHours / weekCompensationOther / benefits
CHARLENE RIGBYCEO
Officer
40$322,542$75
NICOLE R BOICEFOUNDER & CHIEF MISSION OFFICER
Trustee or director, Officer
40$257,792$72
TIMOTHY R EHRHARDSENIOR DIRECTOR, IT
Highest-paid employee
40$170,000$78
KARMEN TRZUPEKSENIOR DIRECTOR, SCIENTIFIC PROGRAMS
Highest-paid employee
40$162,097$6,378
LAUREN ALFORDSENIOR DIRECTOR, MARKETING COMMUNICATION
Highest-paid employee
40$165,000$78
MARIA DELLA ROCCASENIOR DIRECTOR, SUPPORT & EDUCATION
Former
40$160,779$72
VANESSA VOGEL-FARLEYSENIOR DIRECTOR, RESEARCH DATA ANALYTICS & GOVERNA
Former
40$160,000$72
VICTORIA WEISSSENIOR DIRECTOR, FINANCE
Officer
24$124,450$0
BETSY BOGARDDIRECTOR
Trustee or director
1$0$0
KHRYSTAL DAVISDIRECTOR
Trustee or director
1$0$0
ILANA FOGELMANDIRECTOR
Trustee or director
1$0$0
SIMON FROSTCFO
Trustee or director, Officer
1$0$0
PETER GOODHANDDIRECTOR
Trustee or director
1$0$0
CHRISTINA HARTMANSECRETARY
Trustee or director, Officer
1$0$0
HUGH HEMPELDIRECTOR
Trustee or director
1$0$0
RAM IYERDIRECTOR
Trustee or director
1$0$0
WALT KOWTONIUKCHAIR
Trustee or director, Officer
1$0$0
NEIL KUMARDIRECTOR
Trustee or director
1$0$0
CAROLINE LOEWYDIRECTOR
Trustee or director
1$0$0
KATHERINE MAYNARDVICE CHAIR
Trustee or director, Officer
1$0$0
INDU NAVARDIRECTOR
Trustee or director
1$0$0
DAVID PEARCEDIRECTOR
Trustee or director
1$0$0
JOHN REYNDERSDIRECTOR
Trustee or director
1$0$0
MORRIE RUFFINDIRECTOR
Trustee or director
1$0$0
ALVIN SHIHDIRECTOR
Trustee or director
1$0$0

Address and contacts

Address (IRS master file)
1012 14TH ST NW STE 500, WASHINGTON, DC 20005-3406
Principal officer (990 for 2024)
CHARLENE SON RIGBY, 1012 14TH STREET NW SUITE 500, WASHINGTON, DC 20005
Signed the 990
CHARLENE SON RIGBY, CEO
Phone
(949) 248-7273
990-N for 2008 filed under this EIN
Most likely by a chapter, club or affiliate (it says receipts are normally $50,000 or less). Officer: Nicole Boice Founder CEO, 24338 El Toro Road-Suite507, Laguna Woods CA 92637. Mailing address: 24338 El Toro Road-Suite507, Laguna Woods CA 92637. Website: www.theprojectcharity.org
Return prepared by
CLIFTONLARSONALLEN LLP

Mission

GLOBAL GENES' MISSION IS TO DRIVE CHANGE THROUGH THE SUPPORT OF RARE DISEASE PATIENTS AND FAMILIES WHILE EQUIPPING ADVOCACY LEADERS WITH IMPORTANT TOOLS, RESOURCES, MENTORING, AND CONNECTIONS TO FURTHER ADVANCE AWARENESS, EDUCATION, AND RESEARCH.

990 for the year ended December 31, 2024

Program accomplishments

  • GLOBAL GENES' PROGRAMS PROVIDE NEXT-GENERATION PATIENT ADVOCATES WITH A CONTINUUM OF SERVICES TO ACCELERATE THEIR PATH FROM EARLY SUPPORT AND AWARENESS THROUGH RESEARCH READINESS, USING A COLLABORATIVE APPROACH THAT INVOLVES BIOPHARMA, RESEARCHERS AND FUNDERS, WITH DATA AS A CENTRAL CORE. WE AIM TO HAVE SIGNIFICANT IMPACT ON THE LIVES OF PEOPLE LIVING WITH RARE DISEASES BY BRINGING THE COMMUNITY TOGETHER THROUGH OUR PROGRAMS, WHICH ARE DESIGNED TO HELP PARTICIPANTS DEVELOP THE SKILLS THEY SEEK TO BUILD AND LEAD ORGANIZATIONS, BECOME RESEARCH READY, AND PURSUE THE DEVELOPMENT OF TREATMENTS. WE EQUIP ADVOCATES WITH THE KNOWLEDGE, SKILLS, AND CONNECTIONS THEY NEED TO ADVANCE THERAPIES AND AWARENESS FOR THEIR COMMUNITIES.
    Expenses $5,861,349 · grants $175,264 · revenue $1,449,717

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
26-3331487
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2009
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$1,538,482
Income (IRS master file)
$7,145,531

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$7,145,531$7,415,893$1,538,482XML
990December 2023$8,469,402$8,561,859$2,099,140XML
990December 2022$5,557,435$7,700,189$2,294,462IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2018–––IRS
990December 2017–––IRS
990-N for 2008
Officer: Nicole Boice Founder CEO
Filed under this EIN, most likely by a chapter or affiliate
December 31, 2008≤ $50,000 receipts––e-Postcard

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 26-3331487).

Questions about GLOBAL GENES

What is the EIN of GLOBAL GENES?
The employer identification number (EIN) of GLOBAL GENES is 26-3331487.
Is GLOBAL GENES tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2009.
Are donations to GLOBAL GENES tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does GLOBAL GENES file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of GLOBAL GENES due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did GLOBAL GENES last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of GLOBAL GENES?
The 990 for the year ended December 31, 2024 names CHARLENE SON RIGBY.
Who are the officers and directors of GLOBAL GENES?
The 990 for the year ended December 31, 2024 lists 26 people; 8 received compensation from the organization, the highest $319,125 (CHARLENE SON RIGBY, CEO).
How much revenue does GLOBAL GENES have?
On its 990 for the year ended December 31, 2024 it reported revenue of $7,145,531, expenses of $7,415,893 and total assets of $1,538,482 at year end.

Other nonprofits in WASHINGTON

All nonprofits in WASHINGTON · District of Columbia · Voluntary health associations and medical disciplines